Inhibitors of Brutons tyrosine kinase and methods of their use | Patent Number 11319329

US 11319329 B2
Application Number15931437
Publication NumberUS 20210101910 A1
Pendency1 year, 11 months, 25 days
Filled DateMay 13, 2020
Priority DateDec 10, 2015
Publication DateApr 8, 2021
Expiration DateDec 9, 2035
Inventor/ApplicantsJianmei Wei
Genesis M. Bacani
Jennifer D. Venable
Nidhi Arora
Charlotte Pooley Deckhut
Mark S. Tichenor
James P. Edwards
John J. M. Wiener
Scott D. Bembenek
Kevin D. Kreutter
John J.M. Wiener
Joseph Kent Barbay
Brahmananda Ghosh
ExaminesLEESER, ERICH A
Art Unit1624
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.